Varenicline and Bupropion for Alcohol Use Disorder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The COMB study is a randomized double-blind placebo-controlled multicenter trial in Sweden on the efficacy of varenicline and bupropion, in combination and alone, for treatment of alcohol use disorder (AUD). Study design overview: A 13-weeks (91 days) multicenter clinical trial with four parallel groups. 95 subjects per treatment arm will be randomized into the study. 380 subjects with AUD will be randomized in total.
Epistemonikos ID: 917ad4245c14a9e6334b7d43d0ce4c52b139ba44
First added on: May 06, 2024